No evidence to say third Covid wave will impact kids more: Randeep Guleria

While the pandemic had not impacted the younger age group, Guleria said there had been a lot of collateral damage

Randeep Guleria, AIIMS director
Randeep Guleria, AIIMS director | File photo
Ruchika Chitravanshi New Delhi
2 min read Last Updated : May 25 2021 | 12:36 AM IST
There is no indication that the third wave would impact kids more, said Randeep Guleria, Director of All India Institute of Medical Sciences, Delhi, on Monday, stressing that the data of both the waves has shown little impact of the virus on children and those who were affected did not have severe infection.
 
“Those who have supported this theory say that because children have been protected so far, they could have more infections proportionally in the next wave. There is no evidence yet to support this argument,” Guleria said.
 
He also said that the virus enters the human body through ACE (angiotensin-converting enzyme) receptors and kids have less of these than adults.
 
“We should work so that there is no other wave. If we take the learnings of the past then we can avoid any future waves. Viral infections come in waves. We have to minimise them and ensure they don’t come,” Guleria said.
 
The AIIMS chief also said that as the number of recovered patients rises, clinics have to be developed to deal with the treatment of symptoms which persist beyond the disease. He said there was now a better understanding of post-Covid acute syndrome which can continue 8 to 12 weeks and long Covid which can occur if symptoms continue beyond 12 weeks.
 
While the pandemic had not impacted the younger age group, Guleria said there had been a lot of collateral damage. “Everyone knows someone who has suffered from Covid or has lost someone. This is not the pandemic of the younger age group but there has been a lot of collateral damage among them — from education, smartphone addiction, interrupted opportunities, stress and mental issues, gender gaps and nutritional issues,” he said.
 
Some of the common post-Covid issues among those recovered include breathlessness, coughing, anxiety, chronic fatigue syndrome, bodyache, headache and would require symptomatic treatment. “Some of these are due to the inflammatory response of the body,” Guleria said.
 
Brain fog is another complaint being reported in many recovered patients which affects a person’s concentration and can induce insomnia and depression. “Rehabi­litation is necessary for these cases. Medical community has to develop multidisciplinary post-Covid clinics,” Guleria added.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusAIIMSHealth Ministry

Next Story